Mobile website
Archive > Volume 29 Issue 2 > 2022,29(2):150-156. DOI:10.3872/j.issn.1007-385X.2022.02.010 Prev Next
Review
Research progress on cancer immunotherapy targeting TIGIT，CD226 and CD112R
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Keywords:
Project Supported:
Clc Number:
R735.8；R730.2
